Sign in to follow this  
Followers 0
janey

Roche Ends Arthritis Drug Trial

1 post in this topic

Roche Ends Arthritis Drug Trial.

 

Roche said Wednesday it will discontinue the development of the experimental drug, ocrelizumab, that was designed to treat patients suffering from autoimmune disease rheumatoid arthritis. Roche’s own efficacy and safety analysis of ocrelizumab showed the drug's risk profile to be unfavorable when compared to existing treatments. Goran Mijuk. Wall Street Journal. 05/19/10. (Also see: Rheumatoid Arthritis)

 

This item was posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information.


Janey Willis

ISN Support Specialist

(Retired) ISN Assistant Webmaster

(Retired) ISN News Director

(Retired) ISN Technical Writer for Training Manuals

International Scleroderma Network (ISN)

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!


Register a new account

Sign in

Already have an account? Sign in here.


Sign In Now
Sign in to follow this  
Followers 0